DAVID ESCOBEDO: Open Payments
NPI 1477148989 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 56 payments from 17 companies in 2025. Trend: 2023 $1,509 · 2024 $1,219 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $503 |
| ABBVIE INC. | 11 | $262 |
| Sumitomo Pharma America, Inc. | 7 | $256 |
| ACCORD HEALTHCARE, INC. | 7 | $204 |
| PFIZER INC. | 2 | $146 |
| 180 Medical, Inc. | 1 | $83 |
| Boston Scientific Corporation | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Davol Inc. | 1 | $35 |
| UROGEN PHARMA, INC. | 2 | $32 |
Products named: RYBREVANT, GEMTESA, BOTOX, ERLEADA, Camcevi, Xtandi, GENTLECATH, Nubeqa.
Industry payments across AZ — which companies pay providers there.
